Skip to main content
. Author manuscript; available in PMC: 2024 Nov 14.
Published in final edited form as: Birth Defects Res. 2023 Dec 28;116(1):e2294. doi: 10.1002/bdr2.2294

TABLE 2.

A priori potential risk factors by sex and preterm birth status.a

Male preterm Female preterm Male term Female term




Defect Characteristic nb (%*) nb (%) nb (%) nb (%)
Spina bifida Folic acid-containing supplement usec
 Yes 95 (10.8) 111 (12.7) 337 (38.5) 333 (38.0)
 No 50 (17.2) 29 (10.0) 118 (40.5) 94 (32.3)
Maternal smokingc
 Yes 26 (12.6) 32 (15.5) 74 (35.7) 75 (36.2)
 No 121 (12.5) 111 (11.4) 386 (39.8) 353 (36.4)
Pre-pregnancy body mass index
 <30 kg/m2 114 (13.8) 99 (11.9) 321 (38.7) 295 (35.6)
 ≥30 kg/m2 27 (9.3) 37 (12.8) 114 (39.5) 111 (38.4)
Interpregnancy interval
 No previous pregnancies 38 (12.4) 32 (10.5) 131 (42.8) 105 (34.3)
 ≤12 months 43 (17.1) 33 (13.1) 79 (31.4) 97 (38.5)
 >12 months 66 (10.8) 72 (11.8) 246 (40.3) 227 (37.2)
 Total 150 (12.5) 145 (12.0) 470 (39.0) 439 (36.5)
D-transposition of the great arteries Folic acid-containing supplement usec
 Yes 34 (6.2) 15 (2.7) 348 (63.4) 152 (27.7)
 No 9 (5.4) 6 (3.6) 108 (64.3) 45 (26.8)
Maternal smokingc
 Yes 5 (3.7) 8 (5.8) 90 (65.7) 34 (24.8)
 No 39 (6.7) 13 (2.2) 371 (63.8) 159 (27.3)
Pre-pregnancy body mass index
 <30 kg/m2 34 (5.8) 21 (3.6) 372 (63.6) 158 (27.0)
 ≥30 kg/m2 6 (5.0) 1 (0.8) 81 (67.5) 32 (26.7)
Interpregnancy interval
 No previous pregnancies 12 (5.7) 6 (2.9) 126 (60.3) 65 (31.1)
 ≤12 months 8 (6.2) 9 (6.9) 83 (63.9) 30 (23.1)
 >12 months 22 (6.0) 6 (2.9) 245 (66.2) 97 (26.2)
 Total 44 (6.0) 23 (3.1) 466 (63.7) 199 (27.2)
Tetralogy of Fallot Folic acid-containing supplement usec
 Yes 86 (10.0) 70 (8.1) 408 (47.3) 298 (34.6)
 No 20 (9.2) 18 (8.3) 121 (55.5) 59 (27.1)
Maternal smokingc
 Yes 17 (9.6) 17 (9.6) 83 (46.9) 60 (33.9)
 No 89 (9.9) 69 (7.7) 446 (49.5) 297 (33.0)
Pre-pregnancy body mass index
 <30 kg/m2 82 (9.8) 66 (7.9) 407 (48.8) 279 (33.5)
 ≥30 kg/m2 21 (9.5) 19 (8.6) 108 (48.9) 73 (33.0)
Interpregnancy interval
 No previous pregnancies 49 (13.7) 30 (8.4) 166 (46.5) 112 (31.4)
 ≤12 months 16 (8.2) 17 (8.7) 91 (46.7) 71 (36.4)
 >12 months 40 (7.9) 39 (7.7) 266 (52.3) 164 (32.2)
 Total 110 (10.0) 90 (8.2) 540 (49.0) 362 (32.8)
Cleft palate without cleft lip Folic acid-containing supplement usec
 Yes 90 (7.8) 96 (8.4) 408 (35.5) 555 (48.3)
 No 20 (6.1) 28 (8.5) 116 (35.3) 165 (50.2)
Maternal smokingc
 Yes 29 (9.0) 28 (8.7) 115 (35.8) 149 (46.4)
 No 86 (7.4) 99 (8.5) 412 (35.4) 567 (48.7)
Pre-pregnancy body mass index
 <30 kg/m2 99 (8.4) 105 (8.9) 418 (35.3) 563 (47.5)
 ≥30 kg/m2 13 (4.8) 23 (8.5) 101 (37.1) 135 (49.6)
Interpregnancy interval
 No previous pregnancies 41 (10.0) 38 (9.3) 142 (34.7) 188 (46.0)
 ≤12 months 27 (9.3) 27 (9.3) 121 (41.7) 115 (39.7)
 >12 months 47 (6.2) 59 (7.7) 255 (33.4) 402 (52.7)
 Total 117 (7.7) 131 (8.6) 536 (35.3) 733 (48.3)
Cleft lip ± cleft palate Folic acid-containing supplement usec
 Yes 201 (9.1) 96 (4.4) 1257 (57.0) 651 (29.5)
 No 64 (9.4) 24 (3.5) 375 (55.3) 215 (31.7)
Maternal smokingc
 Yes 57 (8.4) 28 (4.1) 385 (56.9) 207 (30.6)
 No 204 (9.3) 93 (4.2) 1241 (56.5) 659 (30.0)
Pre-pregnancy body mass index
 <30 kg/m2 205 (9.1) 94 (4.2) 1280 (57.0) 665 (29.6)
 ≥30 kg/m2 51 (9.7) 23 (4.4) 294 (55.8) 159 (30.2)
Interpregnancy interval
 No previous pregnancies 89 (10.4) 42 (4.9) 491 (57.2) 236 (27.5)
 ≤12 months 43 (7.8) 24 (4.3) 299 (53.9) 189 (34.1)
 >12 months 125 (8.8) 51 (3.6) 822 (57.9) 423 (29.8)
 Total 267 (9.1) 123 (4.2) 1664 (56.8) 876 (29.9)
Longitudinal/intercalary limb deficiency Folic acid-containing supplement usec
 Yes 41 (11.7) 35 (10.0) 161 (45.9) 114 (32.5)
 No 12 (11.4) 16 (15.2) 43 (41.0) 34 (32.4)
Maternal smokingc
 Yes 9 (9.2) 14 (14.3) 39 (39.8) 36 (36.7)
 No 43 (12.2) 36 (10.2) 163 (46.1) 112 (31.6)
Pre-pregnancy body mass index
 <30 kg/m2 42 (11.6) 35 (9.7) 164 (45.3) 121 (33.4)
 ≥30 kg/m2 12 (14.8) 13 (16.1) 30 (37.0) 26 (32.1)
Interpregnancy interval
 No previous pregnancies 24 (15.1) 20 (12.6) 67 (42.1) 48 (30.2)
 ≤12 months 6 (6.7) 8 (9.0) 49 (55.1) 26 (29.2)
 >12 months 22 (11.0) 22 (11.0) 83 (41.3) 74 (36.8)
 Total 54 (11.6) 52 (11.2) 208 (44.7) 151 (32.5)
Transverse limb deficiency Folic acid-containing supplement usec
 Yes 56 (11.2) 47 (9.4) 213 (42.4) 186 (37.1)
 No 18 (12.1) 10 (6.7) 73 (49.0) 48 (32.2)
Maternal smokingc
 Yes 17 (13.0) 13 (9.9) 49 (37.4) 52 (39.7)
 No 55 (10.6) 42 (8.1) 238 (45.7) 186 (35.7)
Pre-pregnancy body mass index
 <30 kg/m2 60 (11.7) 47 (9.2) 219 (42.8) 186 (36.3)
 ≥30 kg/m2 11 (9.4) 8 (6.8) 55 (47.0) 43 (36.8)
Interpregnancy interval
 No previous pregnancies 32 (14.7) 19 (8.7) 89 (40.8) 78 (35.8)
 ≤12 months 14 (13.0) 10 (9.3) 52 (48.2) 32 (29.6)
 >12 months 28 (8.6) 26 (8.0) 147 (45.0) 126 (38.5)
 Total 76 (11.4) 57 (8.5) 293 (43.9) 241 (36.1)
Craniosynostosis Folic acid-containing supplement usec
 Yes 95 (7.8) 39 (3.2) 745 (61.1) 341 (28.0)
 No 21 (8.4) 11 (4.4) 131 (52.6) 86 (34.5)
Maternal smokingc
 Yes 20 (7.9) 13 (5.2) 150 (59.5) 69 (27.4)
 No 97 (7.9) 38 (3.1) 733 (59.6) 362 (29.4)
Pre-pregnancy body mass index
 <30 kg/m2 95 (8.0) 41 (3.5) 710 (60.1) 335 (28.4)
 ≥30 kg/m2 25 (8.4) 9 (3.0) 171 (57.2) 94 (31.4)
Interpregnancy interval
 No previous pregnancies 33 (8.5) 14 (3.6) 237 (61.1) 104 (26.8)
 ≤12 months 34 (11.1) 14 (4.6) 170 (55.6) 88 (28.8)
 >12 months 50 (6.4) 22 (2.8) 475 (61.1) 230 (29.6)
 Total 121 (8.0) 51 (3.4) 904 (59.6) 440 (29.0)
Gastroschisis Folic acid-containing supplement usec
 Yes 295 (31.5) 288 (30.7) 170 (18.1) 185 (19.7)
 No 129 (30.8) 131 (31.3) 87 (20.8) 72 (17.2)
Maternal smokingc
 Yes 145 (30.2) 140 (29.2) 95 (19.8) 100 (20.8)
 No 272 (31.3) 280 (32.3) 163 (18.8) 153 (17.6)
Pre-pregnancy body mass index
 <30 kg/m2 408 (31.9) 386 (30.1) 247 (19.3) 240 (18.7)
 ≥30 kg/m2 19 (25.7) 28 (37.8) 14 (18.9) 13 (17.6)
Interpregnancy interval
 No previous pregnancies 206 (30.0) 215 (31.3) 126 (18.3) 140 (20.4)
 ≤12 months 87 (36.7) 68 (28.7) 41 (17.3) 41 (17.3)
 >12 months 127 (30.3) 127 (30.3) 92 (22.0) 73 (17.4)
 Total 441 (31.4) 430 (30.6) 269 (19.2) 264 (18.8)
a

Row percentages.

b

Numbers vary because of missing values.

c

Month before conception through the second month of pregnancy.